New Medicine by Design-funded research shows lab-made endothelial cells may be able treat liver diseases including hemophilia A
New research is a step forward to cell therapies for liver disease
Medicine by Design-funded researchers generate cells that will impact treatments for bile duct disorders as a result of cystic fibrosis
Newly-generated cells may lead to a deeper understanding of bile duct disease and be a powerful tool for finding new treatments.
Medicine by Design’s Pivotal Experiment Fund invests $1 million in four research teams to bridge the “valley of death” funding gap
Funding gives cutting-edge regenerative medicine concepts impacting heart disease, lung transplantation, degenerative brain disease and end-stage liver disease a pathway to clinical translation.
Harnessing the liver’s power to regenerate
Team led by pioneering stem cell scientist is one step closer to the clinic with cell-based therapies for liver disease.